0001701541-19-000004.txt : 20190716 0001701541-19-000004.hdr.sgml : 20190716 20190716125508 ACCESSION NUMBER: 0001701541-19-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190716 DATE AS OF CHANGE: 20190716 EFFECTIVENESS DATE: 20190716 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc. CENTRAL INDEX KEY: 0001701541 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-329523 FILM NUMBER: 19956695 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-417-5868 MAIL ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aset Therapeutics, Inc. DATE OF NAME CHANGE: 20170321 D/A 1 primary_doc.xml X0708 D/A LIVE 0001701541 Black Diamond Therapeutics, Inc. 139 MAIN STREET CAMBRIDGE MA MASSACHUSETTS 02142 617-417-5868 DELAWARE Aset Therapeutics, Inc. Corporation true 2016 David M. Epstein 139 Main Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Elizabeth Buck 139 Main Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Fang Ni 139 Main Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Ali Behbahani 139 Main Street Cambridge MA MASSACHUSETTS 02142 Director Rajeev Shah 139 Main Street Cambridge MA MASSACHUSETTS 02142 Director Alexander Mayweg 139 Main Street Cambridge MA MASSACHUSETTS 02142 Director Bradley Bolzon 139 Main Street Cambridge MA MASSACHUSETTS 02142 Director Garry E. Menzel 139 Main Street Cambridge MA MASSACHUSETTS 02142 Director Brent Hatzis-Schoch 139 Main Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Biotechnology Decline to Disclose 06b true 0001701541-19-000001 2018-12-21 false true false 0 87224867 44236469 42988398 false 16 0 0 0 false Black Diamond Therapeutics, Inc. /s/ David M. Epstein David M. Epstein President and Chief Executive Officer 2019-07-16